Introduction to Five Trials

Eleven trials, conducted between 2002 and 2010, were identified as eligible, with five trials being from the United States, two from Canada, and one each from Australia and New Zealand, Finland, India, and the United Kingdom.

RESULTS Twenty-two trials with a total of 2,912 patients were included in the analy- sis; the intervention was provided in an individual setting in five trials and in group format in 17.

55) in five trials with 578 participants, as did aminomethylbenzoic acid as reported in one study (RR 0.

Twenty-five trials provided data for quantitative meta-analysis.

Five trials (630 participants) met our inclusion criteria.

Five trials per subject, for one-hundred total trials, were completed.

Researchers provided interventions over 12 to 26 weeks; in five trials, the duration of intervention was 12 or 13 weeks.

In four of five trials with discordant results, the interpretation would have changed had the combined test been used.

The data of five trials enrolling 1762 patients showed that the pooled estimate on mortality of recombinant thrombomodulin use was not statistically significant (risk ratio, 0.

We used probabilistic methods to evaluate the effects of variations in quadriceps muscle forces from five trials of the stair climb task for each subject.

At follow-up of between 4 weeks and 6 months, five trials of Tuina alone or Tuina combined with usual care showed lower rates of relapse compared to usual care alone.

After exclusions, five trials remained for analysis.

Individual patient data from 4965 participants in five trials were included in the Neonatal Oxygenation Prospective Metaanalysis (NeOProM) Collaboration and summarised in several systematic reviews.

Results: From a yield of five trials, physical activity was quantified as active minutes per day, daily energy expenditure and daily steps.

We analysed individual participant data from 22 trials (n=134 537) and detailed summary data from one trial (n=12 705) of statin therapy versus control, plus individual participant data from five trials of more intensive versus less intensive statin therapy (n=39 612).

IMUs were attached to the pelvis, thighs and shanks during five trials of squats, gait, and stair ascending/descending performed at self-selected speed.

Five trials were performed.

023; five trials) was lower in the phytoestrogen group compared to the placebo.

The experiments were conducted across a minimum of five trials for each of the chosen screw sizes.

Five trials (n=78 727 participants) demonstrated no effect of the intervention on use of ACE-I or angiotensin receptor blocker at discharge.

In five trials women had had three or more consecutive miscarriages and in seven trials women had suffered two or more consecutive miscarriages.

Data regarding participants’ capacity status were not available for five trials.

However, the five trials reporting health-related quality of life at the end of the intervention, each showed little or no evidence of a difference between exercise-based cardiac rehabilitation and control.

ResultsTwenty-five trials met the inclusion criteria.

Participants also performed more consistently across the five trials when wearing the ear-protectors.

Five trials were performed with the athletes performing their preferred technique (Skating) and five trials with the athletes running inside a 0.

Thus, the results of the review are based on five trials with 213 participants.

Five trials compared FNB administration to control, and another 3 compared the combination of FNB and LIA to LIA alone.

Nevertheless, in five trials of autoimmune disorders which measured the proportion of Tregs, a higher proportion was observed in the vitamin D group compared to controls at 12 months in all but one trial.

The patients on their usual medications were pulled either forwards or backwards at the level of the shoulders and asked not to take a step in a series of five trials.

The sEMG activity of the pelvic floor muscles was tested during five trials in two positions.

Five trials, including the WHI, enrolled overweight and obese participants (24, 25, 41, 45, 59, 60); 5 focused on participants with medical conditions, such as diabetes or hypercholesterolemia (42, 43, 57, 58, 61); and 1 enrolled older (>64 years) healthy individuals (41).

In two separate testing sessions, five trials of each foot were conducted for the first, second, and third steps.

Artificial tears were used as adjunctive to study medication in all but five trials.

Results Eleven articles were systematically reviewed, and five trials (692 patients) were included in the Meta-analysis.

We assessed all trials as having overall unclear risk of bias due to incomplete reporting of study methods and outcomes; two of the five trials were reported only as conference abstracts.

Five recent trials of higher versus lower PEEP have not shown benefit with higher PEEP, and one of the five trials showed increased harm for patients treated with the open lung strategy.

RESULTS Five trials, inclusive of 843 patients, met this study's eligibility criteria.

RESULTS Twenty-five trials (N = 49,982 subjects) were included.

Five trials included patients with persistent AF (812).

Five trials compared PDE5 inhibitors to placebo in PH secondary to left-heart disease (PH-LHD).

Five trials involving 1289 patients were included.

Sixty-five trials with an overall sample of 9308 patients were included.

Results Twenty-five trials reported a run-in period (5%).

The interventions involved EM in five trials, NMES in three trials, and both EM and NMES in one trial.

Five trials included only women and 40 included both men and women (median, 14.

According to these data, only five trials, including a retrospective analysis, studied pharmacologic dose: three as an antioxidant cocktail and two as monotherapy.

Six multicomponent trials whose interventions incorporated education to promote breastfeeding (four trials), responsive feeding (two trials), and healthy diet (eg, increasing fruit and vegetables and limiting unhealthy snack foods; five trials), delivered through home visits or at baby health clinics, reported relative reductions in body mass index (BMI) at the end of intervention.

This intertrial effect is not only determined by face attractiveness on the previous trial, but also depends on the faces shown up to five trials back.

ResultsFive trials involving 4300 participants were included in our meta-analysis.

Results: A total of 10 RCTs were included, six trials assessing timing of oral refeeding and five trials assessing method of oral refeeding.

Data from five trials (n = 259) in people with stroke suggest that aquatic physiotherapy improves measures of balance, walking, mobility, and activities of daily living.